Modulight Spotlights: LASER-SHARP RESEARCH – April 2025
This month it is time to highlight a promising study by Sumeyra Gokalp et al. from University of Massachusetts and Tufts University, USA. Clinical application of many photosensitive drugs is constrained by poor solubility, rapid clearance, and inadequate tumor accumulation. To tackle these drug delivery challenges, researchers constructed an innovative liquid metal nanoparticle platform, which has tumor cell targeting and enhanced encapsulation of verteporfin. Extensive in vitro characterization with the help of ML6600 laser showed effective in vitro phototoxicity, high drug release, good photostability, and biocompatibility. Integration of better drug delivery, light-activated therapy, and imaging capabilities within a single platform makes it attractive candidate for more effective and personalized cancer therapy.
Modulight is very happy to be supporting this research. We would like to deliver our warmest congratulations to the research team!
#Laser-Sharp Research #breastcancer #cancer #research #immunotherapy #immunology
Modulight products used:
Read more:
About Modulight’s LASER-SHARP RESEARCH concept:
Laser-Sharp Research is a concept where our scientific board highlights cutting-edge scientific research articles from our customers. Important selection criteria are that Modulight and laser product are mentioned in the publication, the impact and relevance of the results, clinical translatability, as well as scientific quality of the journal. The nominated research groups will be rewarded to encourage the great work done.
Contact Us
Do you have questions or comments related to this LASER-SHARP RESEARCH nomination? Maybe your group has done significant research that your would like us to spotlight? Or would you like to request literature? Please drop us a line!